MaxCyte


Provider of non-viral electroporation platforms, consumables, and laboratory services for research, discovery and clinical-scale cell and gene therapy manufacturing. Offers scalable static and flow electroporation systems, GMP-compatible consumables and process support, sequencing-based off-target assessment workflows for genome editing (including base editors), and regulatory documentation support to assist IND/CTA/BLA submissions.

Industries

Biopharma
Biotechnology
Commercial
Biotechnology Research

Nr. of Employees

medium (51-250)

MaxCyte

Waltham, Massachusetts, United States


Patents

Methods for modifying genomic DNA

US-11608511-B2

View Details

Engineering and delivery of therapeutic compositions of freshly isolated cells

US-10660917-B2

View Details

Methods and compositions for generating stable transfected cells

US-10316335-B2

View Details

Engineering and delivery of therapeutic compositions of freshly isolated cells

US-9669058-B2

View Details

Methods and devices related to a regulated flow electroporation chamber

US-9546350-B2

View Details

Engineering and delivery of therapeutic compositions of freshly isolated cells

US-9132153-B2

View Details
View All Patents

Products

Electroporation instruments (static and flow platforms)

Laboratory and manufacturing instruments enabling transfection of primary cells, cell lines and large cell batches for discovery, process development and cGMP-compatible manufacturing.

Processing assemblies and reagents

Disposable and reusable consumable assemblies and buffer formulations intended to support desired scale and throughput for electroporation workflows.

Flow Electroporation

Clinically validated and cGMP compliant flow electroporation technology capable of transfecting up to 20 billion cells.

FLOW ELECTROPORATION Processing Assembly, Research Grade, 5 mL to 20 mL volume

Flow electroporation processing assembly, research grade, 5 mL to 20 mL volume, sample and collection PVC bags with luer locking syringe ports, closed system, bioweldable tubing, single pack.

CL-2

Transfect up to 20 billion cells in less than 30 minutes with this Flow Electroporation enabled processing assembly.

CL-2 GMP

Flow Electroporation enabled processing assembly for clinical production up to 100 mL working volume.

View All Products

Services

Provision of static and flow electroporation instruments, optimization support, training, and field application services for research and manufacturing customers.

Contract laboratory services providing nomination and confirmation sequencing assays to identify and prioritize editing-related risks for genome editing programs, including workflows applicable to base editors.

Regulatory filing support leveraging maintained regulatory technical files, audit readiness assistance, validation guidance and on-site compliance support for manufacturing operations.

In-person and virtual seminars and workshops covering scalable electroporation, genome editing workflows, process development and case studies in cell engineering for academic and industry researchers.

Expertise Areas

  • Cell and gene therapy process development
  • Non-viral transfection and electroporation
  • Genome-editing off-target detection and confirmation
  • GMP-compatible manufacturing support and consumables
  • Show More (4)

Key Technologies

  • Non-viral electroporation (static and flow)
  • High-throughput multiwell electroporation
  • Ribonucleoprotein (RNP) delivery
  • Single-stranded HDR template delivery
  • Show More (5)

News & Updates

In-person seminar on scalable cell engineering and gene editing workflows with academic and industry speakers, covering primary cell, stem cell and cell line engineering and case studies.

Seminar presenting electroporation-enabled process development and case studies for non-viral cell engineering and CRISPR-based manufacturing approaches.

In-person and virtual seminar highlighting non-viral cell engineering and clinical-scale manufacturing workflows, including presentations from academic GMP facility leaders.

On-demand seminar covering scalable electroporation platform applications, including CRISPR, protein production and viral production case studies.

Webinar showcasing non-viral CAR-NK cell engineering approaches and process development case studies enabling clinical advancement.

Announcement describing expansion of off-target nomination methods to support base editor assessment and related sequencing workflows.

View All News

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.